CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 76 enrolled
Drug / intervention
Lithium +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01880957
NCT01880957N/ACompleted

Pathophysiology and Treatment of Bipolar Disorder as Assessed by in Vivo Imaging

Stony Brook University·interventional·Posted Jun 19, 2013·Updated Jul 20, 2022

In Brief

A clinical study evaluating Lithium and Lamotrigine for Bipolar Disorder and 2 related conditions. Completed, enrolled 76 participants across 1 site.

Detailed Summary

The primary aims of this study are to: 1. Quantify serotonin transporter (5-HTT) binding potential (BP) in vivo in bipolar disorder patients (BPD) during a major depressive episode (MDE). 2. Assess the effect of lithium treatment of bipolar disorder on 5-HTT. 3. Assess the effect of lithium treatment of bipolar disorder on 5-HT1A BP. 4. Assess the effect of lamotrigine treatment of bipolar disorder on 5-HTT and 5-HT1A BP. 5. Assess the effect of lithium treatment of unipolar depression on 5-HTT BP.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 19, 2013
Enrollment StartNov 8, 2011
Primary CompletionJun 23, 2017
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 13.0 years ago

Interventions

Lithiumdrug

Lamotriginedrug